Evidence map›Paper›PMID 41146214›Full record

ArticleOrphanet journal of rare diseases2025

Addressing psychosocial vulnerability in rare diseases: a call to action from a European expert consensus study.

Rosanne M Smits, Aukje Aerts, Teodor Angelov, Marissa Bentele, Ivo de Blaauw, Michaela Dellenmark-Blom, Saskia F A Duijts, Krister Fjermestad, Monica Franscini, Caterina Grano and 13 more

Abstract readConsensus Statement
In one paragraph

Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. [Rare diseases: a concept for a structured diagnostic pathway].Innere Medizin (Heidelberg, Germany) · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Rosanne M SmitsDepartment of Medical Psychology, Amalia Children's Hospital, Radboud University Medical Centre, 9101, 6500 HB, Nijmegen, The Netherlands.ORCID 0000-0003-2682-2654
Aukje AertsDepartment of Medical Psychology, Amalia Children's Hospital, Radboud University Medical Centre, 9101, 6500 HB, Nijmegen, The Netherlands.
Teodor AngelovDepartment of Neurology, Alexandrovska University Hospital, Medical University of Sofia, Sofia, Bulgaria.
Marissa BenteleDepartment of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Tübingen, Germany.
Ivo de BlaauwDepartment of Pediatric Surgery, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, The Netherlands.
Michaela Dellenmark-BlomDepartment of Pediatrics, University of Gothenburg Institute of Clinical Sciences, Gothenburg, Sweden.
Saskia F A DuijtsDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation (Integraal Kankercentrum Nederland, IKNL), Utrecht, The Netherlands.
Krister FjermestadDepartment of Psychology, University of Oslo, Oslo, Norway.
Monica FransciniDepartment of Psychology, SS Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy.
Caterina GranoDepartment of Psychology, Sapienza University of Rome, Rome, Italy.
Sigrid HendriksVSOP-Vereniging Samenwerkende Ouder En Patiëntenorganisaties, Soest, The Netherlands.
Laura InhesternDepartment of Medical Psychology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Thomas KennyRare Diseases International, Paris, France.
Charlotte von der LippeDepartment of Medical Genetics, Telemark Hospital Trust, Skien, Norway.
Loes OomenDepartment of Pediatric Urology, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, The Netherlands.
Jan Peter RakeDepartment of Pediatrics, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, The Netherlands.
Andre B RietmanDepartment of Child and Adolescent Psychiatry/Psychology, Sophia Childrens Hospital, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Iris A L M van RooijIQ Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands.
Chris M VerhaakDepartment of Medical Psychology, Amalia Children's Hospital, Radboud University Medical Centre, 9101, 6500 HB, Nijmegen, The Netherlands. chris.verhaak@radboudumc.nl.
Nicoline B M VoetDepartment of Rehabilitation, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands.
Holly WaltonInstitute of Epidemiology and Health Care, University College London, London, UK.
Wendy van Zelst-StamsDepartment of Human Genetics, Radboud Institute for Health Science, Radboud University Medical Centre, Nijmegen, The Netherlands.
Linda KwakkenbosDepartment of Psychiatry, Radboud University Medical Centre, Nijmegen, The Netherlands.

Funding

European Joint Programme for Rare Diseases EJP-RD
6 · The paper itself

Abstract

backgroundPersons living with a rare disease (PLWRD) often encounter burdensome and stressful events that may severely affect their psychosocial vulnerability. There is an urgent need for psychosocial support in PLWRD. We aimed to reach consensus about the most prominent psychosocial needs in rare diseases and future research directions to develop adequate psychosocial support for rare diseases.

methodsAn adapted nominal group technique (NGT) session was conducted in Nijmegen (The Netherlands) with a European expert group of professionals working in the rare disease field. Seventeen participants from seven different European countries took part in the NGT session (seven researchers, two therapists, one patient representative, four clinicians/researchers, and three clinicians), and 23 participants took part in the overall workshop and contributed to this consensus statement.

resultsAn initial list of 57 psychosocial needs was aligned with Pickers' theoretical framework of eight principles of care: patient-centredness, emotional support, access to care, information and education, partner and family involvement, respect and autonomy, care organisation, continuity of care, and physical comfort. For future research directions, six items remained with main focal points addressing international collaborations, inclusivity in rare diseases (patient representatives, ethnic minorities, and elderly), identifying common needs across rare diseases, and translating psychosocial models from common chronic conditions.

conclusionsA consensus meeting was organised that primarily addressed the psychosocial vulnerability in rare diseases. With the outcomes of this study, we aim for better representation of psychosocial vulnerability within health care and to create future research directions to reduce psychosocial vulnerability in rare diseases.

Indexed as

Rare DiseasesEuropeHumansConsensus workshopPsychosocial factorsQuality of lifeRare diseases

Identifiers

PMID41146214
PMCPMC12560521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.